Qingdao Haier Biomedical Co Ltd Cash Flow-to-Debt Ratio
Qingdao Haier Biomedical Co Ltd cash flow-to-debt ratio. Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2023, meaning its operating cash flow of CN¥7.33 Million could theoretically repay 0% of its total liabilities (CN¥1.15 Billion) in one year. Check how high is Qingdao Haier Biomedical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Qingdao Haier Biomedical Co Ltd (2016–2025)
Cash flow-to-debt ratio of Qingdao Haier Biomedical Co Ltd from 2016 to 2025. Historical debt coverage capacity for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Check 688139 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Qingdao Haier Biomedical Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Qingdao Haier Biomedical Co Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Qingdao Haier Biomedical Co Ltd. For the full cash flow conversion analysis, see 688139 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥267.89 Million | CN¥1.17 Billion | ▼ -8.1% |
| 2024 | 0.25x | CN¥291.67 Million | CN¥1.17 Billion | ▲ +8.6% |
| 2023 | 0.23x | CN¥249.26 Million | CN¥1.09 Billion | ▼ -51.3% |
| 2022 | 0.47x | CN¥632.43 Million | CN¥1.34 Billion | ▼ -5.9% |
| 2021 | 0.50x | CN¥632.43 Million | CN¥1.26 Billion | ▼ -16.6% |
| 2020 | 0.60x | CN¥696.62 Million | CN¥1.16 Billion | ▲ +24.6% |
| 2019 | 0.48x | CN¥280.49 Million | CN¥581.08 Million | ▲ +260.9% |
| 2018 | 0.13x | CN¥149.00 Million | CN¥1.11 Billion | ▼ -48.1% |
| 2017 | 0.26x | CN¥148.32 Million | CN¥575.92 Million | ▼ -73.6% |
| 2016 | 0.97x | CN¥220.72 Million | CN¥226.46 Million | — |